Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.

Clinical advances in hematology & oncology : H&O

Volumn 6, Issue 11, 2008, Pages 825-833

  Gaston, Cindy ^a   Kolesar, Jill ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYTOCHROME P450 2D6; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; METABOLISM; PROGNOSIS;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYTOCHROME P-450 CYP2D6; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; TAMOXIFEN;

EID: 61449209055     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)